Literature DB >> 23527885

COMT, neuropsychological function and brain structure in schizophrenia: a systematic review and neurobiological interpretation.

Elisa Ira1, Martina Zanoni, Mirella Ruggeri, Paola Dazzan, Sarah Tosato.   

Abstract

BACKGROUND: Endophenotypes in genetic psychiatry may increase our understanding of the molecular mechanisms underlying disease risk and its manifestations. We sought to investigate the link between neuropsychological impairments and brain structural abnormalities associated with the COMT Val(158)Met polymorphism in patients with schizophrenia to improve understanding of the pathophysiology of this disorder.
METHODS: We performed a systematic review using studies identified in PubMed and MEDLINE (from the date of the first available article to July 2012). Our review examined evidence of an association between the COMT Val(158)Met polymorphism and both neuropsychological performance and brain structure in patients with psychosis, in their relatives and in healthy individuals (step 1). The review also explored whether the neuropsychological tasks and brain structures identified in step 1 met the criteria for an endophenotype (step 2). Then we evaluated evidence that the neuropsychological endophenotypes identified in step 2 are associated with the brain structure endophenotypes identified in that step (step 3). Finally, we propose a neurobiological interpretation for this evidence.
RESULTS: A poorer performance on the n-back task and the Continuous Performance Test (CPT) and smaller temporal and frontal brain areas were associated with the COMT Val allele in patients with schizophrenia and their relatives and met most of the criteria for an endophenotype. It is possible that the COMT Val(158)Met polymorphism therefore contributes to the development of these neuropsychological and brain structural endophenotypes of schizophrenia, in which the prefrontal cortex may represent the neural substrate underlying both n-back and CPT performances. LIMITATIONS: The association between a single genetic variant and an endophenotype does not necessarily imply a causal relationship between them.
CONCLUSION: This evidence and the proposed interpretation contribute to explain, at least in part, the biological substrate of 4 important endophenotypes that characterize schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23527885      PMCID: PMC3819150          DOI: 10.1503/jpn.120178

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  150 in total

1.  Influence of dopaminergic and serotoninergic genes on working memory in healthy subjects.

Authors:  Monika Wiłkość; Joanna Hauser; Marta Tomaszewska; Monika Dmitrzak-Weglarz; Maria Skibińska; Aleksandra Szczepankiewicz; Alina Borkowska
Journal:  Acta Neurobiol Exp (Wars)       Date:  2010       Impact factor: 1.579

2.  Met158 variant of the catechol-O-methyltransferase genotype is associated with thicker cortex in adult brain.

Authors:  A Cerasa; A Cherubini; A Quattrone; M C Gioia; P Tarantino; G Annesi; F Assogna; C Caltagirone; G Spalletta
Journal:  Neuroscience       Date:  2010-02-26       Impact factor: 3.590

Review 3.  Genes, cognition and brain through a COMT lens.

Authors:  D Dickinson; B Elvevåg
Journal:  Neuroscience       Date:  2009-05-13       Impact factor: 3.590

4.  The effect of COMT, BDNF, 5-HTT, NRG1 and DTNBP1 genes on hippocampal and lateral ventricular volume in psychosis.

Authors:  A Dutt; C McDonald; E Dempster; D Prata; M Shaikh; I Williams; K Schulze; N Marshall; M Walshe; M Allin; D Collier; R Murray; E Bramon
Journal:  Psychol Med       Date:  2009-07-02       Impact factor: 7.723

5.  The effect of the COMT val(158)met polymorphism on neural correlates of semantic verbal fluency.

Authors:  Axel Krug; Valentin Markov; Abigail Sheldrick; Sören Krach; Andreas Jansen; Klaus Zerres; Thomas Eggermann; Tony Stöcker; N Jon Shah; Tilo Kircher
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-04-21       Impact factor: 5.270

Review 6.  Can the role of genetic factors in schizophrenia be enlightened by studies of candidate gene mutant mice behaviour?

Authors:  Rodolfo Mazzoncini; Michele Zoli; Sarah Tosato; Antonio Lasalvia; Mirella Ruggeri
Journal:  World J Biol Psychiatry       Date:  2009       Impact factor: 4.132

7.  Inefficient neural activity in patients with schizophrenia and nonpsychotic relatives of schizophrenic patients: evidence from a working memory task.

Authors:  Susanne Karch; Gregor Leicht; Ina Giegling; Jürgen Lutz; Jörg Kunz; Moritz Buselmeier; Patric Hey; Alexander Spörl; Lorenz Jäger; Thomas Meindl; Oliver Pogarell; Hans-Jürgen Möller; Ulrich Hegerl; Dan Rujescu; Christoph Mulert
Journal:  J Psychiatr Res       Date:  2009-05-07       Impact factor: 4.791

8.  COMT val108/158 met genotype affects neural but not cognitive processing in healthy individuals.

Authors:  Nancy A Dennis; Anna C Need; Kevin S LaBar; Sheena Waters-Metenier; Elizabeth T Cirulli; James Kragel; David B Goldstein; Roberto Cabeza
Journal:  Cereb Cortex       Date:  2009-07-29       Impact factor: 5.357

9.  Specific brain structural abnormalities in first-episode schizophrenia. A comparative study with patients with schizophreniform disorder, non-schizophrenic non-affective psychoses and healthy volunteers.

Authors:  Benedicto Crespo-Facorro; Roberto Roiz-Santiáñez; Rocío Pérez-Iglesias; Diana Tordesillas-Gutiérrez; Ignacio Mata; José Manuel Rodríguez-Sánchez; Enrique Marco de Lucas; José Luis Vázquez-Barquero
Journal:  Schizophr Res       Date:  2009-09-30       Impact factor: 4.939

10.  Lesion evidence that two distinct regions within prefrontal cortex are critical for n-back performance in humans.

Authors:  Ami Tsuchida; Lesley K Fellows
Journal:  J Cogn Neurosci       Date:  2009-12       Impact factor: 3.225

View more
  22 in total

1.  Genetics and brain morphology.

Authors:  Lachlan T Strike; Baptiste Couvy-Duchesne; Narelle K Hansell; Gabriel Cuellar-Partida; Sarah E Medland; Margaret J Wright
Journal:  Neuropsychol Rev       Date:  2015-03-14       Impact factor: 7.444

2.  Genetic Variants Within Molecular Targets of Antipsychotic Treatment: Effects on Treatment Response, Schizophrenia Risk, and Psychopathological Features.

Authors:  Marco Calabrò; Stefano Porcelli; Concetta Crisafulli; Sheng-Min Wang; Soo-Jung Lee; Changsu Han; Ashwin A Patkar; Prakash S Masand; Diego Albani; Ilaria Raimondi; Gianluigi Forloni; Sofia Bin; Carlotta Cristalli; Vilma Mantovani; Chi-Un Pae; Alessandro Serretti
Journal:  J Mol Neurosci       Date:  2017-11-21       Impact factor: 3.444

Review 3.  The link between schizophrenia and substance use disorder: A unifying hypothesis.

Authors:  Jibran Y Khokhar; Lucas L Dwiel; Angela M Henricks; Wilder T Doucette; Alan I Green
Journal:  Schizophr Res       Date:  2017-04-14       Impact factor: 4.939

4.  COMT Genetic Reduction Produces Sexually Divergent Effects on Cortical Anatomy and Working Memory in Mice and Humans.

Authors:  Sara Sannino; Alessandro Gozzi; Antonio Cerasa; Fabrizio Piras; Diego Scheggia; Francesca Managò; Mario Damiano; Alberto Galbusera; Lucy C Erickson; Davide De Pietri Tonelli; Angelo Bifone; Sotirios A Tsaftaris; Carlo Caltagirone; Daniel R Weinberger; Gianfranco Spalletta; Francesco Papaleo
Journal:  Cereb Cortex       Date:  2014-03-21       Impact factor: 5.357

5.  COMT genotype and response to cognitive remediation in schizophrenia.

Authors:  Jean-Pierre Lindenmayer; Anzalee Khan; Herbert Lachman; Susan R McGurk; Abraham Goldring; Amod Thanju; Saurabh Kaushik
Journal:  Schizophr Res       Date:  2015-08-06       Impact factor: 4.939

6.  COMT val158met polymorphism and molecular alterations in the human dorsolateral prefrontal cortex: Differences in controls and in schizophrenia.

Authors:  Abhay A Shukla; Manish Jha; Thomas Birchfield; Shibani Mukherjee; Kelly Gleason; Salim Abdisalaam; Aroumougame Asaithamby; Beverley Adams-Huet; Carol A Tamminga; Subroto Ghose
Journal:  Schizophr Res       Date:  2016-03-24       Impact factor: 4.939

7.  Methionine sulfoxide reductase regulates brain catechol-O-methyl transferase activity.

Authors:  Jackob Moskovitz; Consuelo Walss-Bass; Dianne A Cruz; Peter M Thompson; Marco Bortolato
Journal:  Int J Neuropsychopharmacol       Date:  2014-04-15       Impact factor: 5.176

8.  COMT and STH polymorphisms interaction on cognition in schizophrenia.

Authors:  Marta Bosia; Alessandro Pigoni; Adele Pirovano; Cristina Lorenzi; Marco Spangaro; Mariachiara Buonocore; Margherita Bechi; Federica Cocchi; Carmelo Guglielmino; Placido Bramanti; Enrico Smeraldi; Roberto Cavallaro
Journal:  Neurol Sci       Date:  2014-10-05       Impact factor: 3.307

9.  Depression, Cytokine, and Cytokine by Treatment Interactions Modulate Gene Expression in Antipsychotic Naïve First Episode Psychosis.

Authors:  Cristiano Noto; Vanessa Kiyomi Ota; Marcos Leite Santoro; Eduardo Sauerbronn Gouvea; Patricia Natalia Silva; Leticia Maria Spindola; Quirino Cordeiro; Rodrigo Affonseca Bressan; Ary Gadelha; Elisa Brietzke; Sintia Iole Belangero; Michael Maes
Journal:  Mol Neurobiol       Date:  2015-10-22       Impact factor: 5.590

10.  RNA splicing is a primary link between genetic variation and disease.

Authors:  Yang I Li; Bryce van de Geijn; Anil Raj; David A Knowles; Allegra A Petti; David Golan; Yoav Gilad; Jonathan K Pritchard
Journal:  Science       Date:  2016-04-28       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.